We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+7.56%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$310B
AUM Growth
+$8.85B
Cap. Flow
-$12.9B
Cap. Flow %
-4.15%
Top 10 Hldgs %
14.55%
Holding
10,459
New
1,343
Increased
3,599
Reduced
4,168
Closed
927

Sector Composition

Rank Sector Weight
1 Technology 11.88%
2 Financials 7.38%
3 Consumer Discretionary 6.3%
4 Healthcare 6.09%
5 Communication Services 4.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBPH icon
9126
Theravance Biopharma
TBPH
$874M
$1K ﹤0.01%
100
-218,938
-100% -$4.11M
TECS icon
9127
Direxion Daily Technology Bear 3x ETF
TECS
$69.6M
-1
Closed -$6.17K
TRTY icon
9128
Cambria Trinity ETF
TRTY
$144M
$1K ﹤0.01%
+19
New +$527
UHG
9129
DELISTED
United Homes Group
UHG
$1K ﹤0.01%
+100
New +$975
USAU icon
9130
US Gold Corp
USAU
$214M
$1K ﹤0.01%
89
-1,748
-95% -$19.5K
VIST icon
9131
Vista Energy
VIST
$7.84B
$1K ﹤0.01%
300
+200
+200% +$640
VTGN icon
9132
VistaGen Therapeutics
VTGN
$9.89M
$1K ﹤0.01%
8
-352
-98% -$26.1K
XFOR icon
9133
X4 Pharmaceuticals
XFOR
$375M
$1K ﹤0.01%
4
-129
-97% -$32.4K
XOMA
9134
DELISTED
Xoma
XOMA
$1K ﹤0.01%
16
-1,267
-99% -$42.4K
MAAS
9135
Maase Inc
MAAS
$7.87B
$1K ﹤0.01%
2
-2
-50% -$624
RPT
9136
Rithm Property Trust
RPT
$95.8M
$1K ﹤0.01%
14
-683
-98% -$50.3K
QNTM
9137
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$18.5M
$1K ﹤0.01%
8
-9
-53% -$1.04K
SAIH
9138
SAIHEAT Ltd
SAIH
$32.6M
$1K ﹤0.01%
+7
New +$1.01K
UOKA
9139
DELISTED
MDJM Ltd
UOKA
0
HTB
9140
HomeTrust Bancshares
HTB
$860M
$1K ﹤0.01%
40
-2,847
-99% -$78.1K
CYTHW
9141
DELISTED
Cyclo Therapeutics, Inc. Warrant
CYTHW
$1K ﹤0.01%
205
-788
-79% -$2.91K
UTRN
9142
DELISTED
Vesper US Large Cap Short-Term Reversal Strategy ETF
UTRN
$1K ﹤0.01%
26
-169
-87% -$5.61K
LUMO
9143
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$1K ﹤0.01%
111
-1,226
-92% -$13.6K
SOC.WS
9144
DELISTED
Sable Offshore Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
SOC.WS
$1K ﹤0.01%
+475
New +$350
PHGE.U
9145
DELISTED
BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock
PHGE.U
$1K ﹤0.01%
+15
New +$1.29K
GRIN
9146
DELISTED
Grindrod Shipping Holdings Ltd. Ordinary Shares
GRIN
$1K ﹤0.01%
63
-4,953
-99% -$42.7K
SDPI
9147
DELISTED
Superior Drilling Products Inc.
SDPI
$1K ﹤0.01%
+784
New +$657
EFTRW
9148
DELISTED
eFFECTOR Therapeutics, Inc. Warrant
EFTRW
$1K ﹤0.01%
617
+545
+757% +$441
FNCB
9149
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
$1K ﹤0.01%
90
-8,356
-99% -$60.5K
QDRO
9150
DELISTED
Quadro Acquisition One Corp. Class A Ordinary Shares
QDRO
$1K ﹤0.01%
+100
New +$972

Similar funds

UBS Group's Q2 2021 Portfolio in Review

As of Q2 2021, UBS Group held 10,459 positions worth $310B, up 2.9% from $301B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS Group withdrew a net $12.9B in Q2 2021, closing 927 positions and reducing 4,168 holdings. Its most notable exit was INPHI CORPORATION, an estimated $121M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, UBS Group opened a new position in Dimensional US Core Equity 2 ETF worth $42.4M.

  • UBS Group's largest Q2 2021 buy was Dimensional US Core Equity 2 ETF: 1,571,036 shares worth $42.4M.
  • UBS Group added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, an estimated $1.02B increase.
  • UBS Group's biggest Q2 2021 reduction was Alibaba, cutting an estimated $2.65B.
  • UBS Group fully exited INPHI CORPORATION in Q2 2021, selling an estimated $121M.
  • UBS Group's ten largest holdings make up 15% of its $310B portfolio in Q2 2021.
  • UBS Group opened 1,343 new positions and closed 927 in Q2 2021.
  • UBS Group's portfolio value rose 2.9% quarter-over-quarter to $310B.

Based on UBS Group's 13F filing for Q2 2021, filed 13 Aug 2021.